Table 3.
Preoperative and intraoperative risk factors that increase the risk of PHLF by 5%
| Feature name | Increases PHLF risk by 5% |
|---|---|
| Preoperative risk factor | |
| Preoperative INR | > 1.0405 |
| Preoperative sodium (mEq/L) | < 139.1796 |
| Preoperative albumin (g/dL) | < 3.9497 |
| ASA Class | > 1.9419 |
| Preoperative total bilirubin (mg/dL) | > 0.65 |
| Sex | Male |
| Preoperative AST (units/L) | > 35.7 |
| Preoperative PTT (sec) | > 29.2 |
| Tumor M stage | > 1.52 |
| Preoperative platelets (x109/L) | < 223 |
| Use of neoadjuvant therapy | Yes |
| Number of tumors | > 5 |
| Normal liver texture | Abnormal |
| Number of benign lesions | > 3 |
| Intraoperative risk factor | |
| Use of intra or postoperative transfusions for bleeding | Yes |
| Use of total right lobectomy | Yes |
| Operative time (min) | > 266.51 |
| Open surgical approach (planned) | Yes |
| Use of trisegmentectomy | Yes |
| Use of Pringle maneuver | Yes |
| Use of hepaticojejunostomy reconstruction | Yes |